Skip to main content
Erschienen in: Clinical Journal of Gastroenterology 6/2023

05.09.2023 | Case Report

Laparoscopic hepatectomy for hepatocellular carcinoma in patients with hemophilia A and B: a report of two cases

verfasst von: Mariko Tsukagoshi, Norifumi Harimoto, Kenichiro Araki, Norihiro Ishii, Kei Hagiwara, Kouki Hoshino, Kunio Yanagisawa, Yoshiyuki Ogawa, Hiroshi Handa, Ken Shirabe

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Hepatocellular carcinoma (HCC) is a life-threatening complication of hemophilia. Reports of patients with hemophilia undergoing hepatectomy for HCC are scarce. We report the cases of patients with hemophilia A and B who underwent laparoscopic hepatectomy for HCC. Perioperative hemophilia management was supervised by the hematology team. The patients received coagulation factor bolus injections immediately preoperatively, then continuous intravenous infusions intra- and postoperatively. A laparoscopic segment II partial hepatectomy was performed in case 1. Due to severe adhesions, intermittent pedicle clamping could not be used during parenchymal transection. The surgical duration was 235 min, and the estimated blood loss was 13 mL. The patient was discharged 11 days postoperatively without any complications. In case 2, laparoscopic partial hepatectomy for segments V/VI was performed. An intermittent pedicle clamp (Pringle method) was used during parenchymal transection. The surgical duration and estimated blood loss were 219 min and 18 mL, respectively. The patient was discharged 8 days postoperatively without complications. In both cases, intraoperative bleeding was minimal, and the patients were discharged without postoperative hemorrhage with appropriate perioperative coagulation factor management. Laparoscopic hepatectomy can be safely performed and appears to be a feasible treatment option for HCC in patients with hemophilia.
Literatur
1.
Zurück zum Zitat Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al. Guidelines for the management of hemophilia. Haemophilia. 2013;19:e1-47.CrossRefPubMed Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al. Guidelines for the management of hemophilia. Haemophilia. 2013;19:e1-47.CrossRefPubMed
2.
Zurück zum Zitat Darby SC, Ewart DW, Giangrande PL, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors’ Organisation. Lancet. 1997;350:1425–31.CrossRefPubMed Darby SC, Ewart DW, Giangrande PL, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors’ Organisation. Lancet. 1997;350:1425–31.CrossRefPubMed
3.
Zurück zum Zitat Goedert JJ, Eyster ME, Lederman MM, et al. End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood. 2002;100:1584–9.PubMed Goedert JJ, Eyster ME, Lederman MM, et al. End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood. 2002;100:1584–9.PubMed
4.
Zurück zum Zitat Inokawa Y, Sugimoto H, Kanda M, et al. Hepatectomy for hepatocellular carcinoma in patients with hemophilia. J Hepato-Bil Pancreat Sci. 2014;21:824–8.CrossRef Inokawa Y, Sugimoto H, Kanda M, et al. Hepatectomy for hepatocellular carcinoma in patients with hemophilia. J Hepato-Bil Pancreat Sci. 2014;21:824–8.CrossRef
5.
Zurück zum Zitat Kobayashi K, Kokudo T, Yamaguchi T, et al. Hepatectomy in patients with inherited blood coagulation disorders can be safely performed with adequate coagulation factor replacement. Haemophilia. 2019;25:463–7.CrossRefPubMed Kobayashi K, Kokudo T, Yamaguchi T, et al. Hepatectomy in patients with inherited blood coagulation disorders can be safely performed with adequate coagulation factor replacement. Haemophilia. 2019;25:463–7.CrossRefPubMed
6.
Zurück zum Zitat Araki K, Harimoto N, Ishii N, et al. Optimal indications for an intercostal port for the superior segments in laparoscopic partial liver resection. Asian J Endosc Surg. 2020;13:382–9.CrossRefPubMed Araki K, Harimoto N, Ishii N, et al. Optimal indications for an intercostal port for the superior segments in laparoscopic partial liver resection. Asian J Endosc Surg. 2020;13:382–9.CrossRefPubMed
7.
Zurück zum Zitat Jones RM, Moulton CE, Hardy KJ. Central venous pressure and its effect on blood loss during liver resection. Br J Surg. 1998;85:1058–60.CrossRefPubMed Jones RM, Moulton CE, Hardy KJ. Central venous pressure and its effect on blood loss during liver resection. Br J Surg. 1998;85:1058–60.CrossRefPubMed
8.
Zurück zum Zitat Iguchi T, Ikegami T, Fujiyoshi T, et al. Low positive airway pressure without positive end-expiratory pressure decreases blood loss during hepatectomy in living liver donors. Dig Surg. 2017;34:192–6.CrossRefPubMed Iguchi T, Ikegami T, Fujiyoshi T, et al. Low positive airway pressure without positive end-expiratory pressure decreases blood loss during hepatectomy in living liver donors. Dig Surg. 2017;34:192–6.CrossRefPubMed
9.
Zurück zum Zitat Kobayashi S, Honda G, Kurata M, et al. An experimental study on the relationship among airway pressure, pneumoperitoneum pressure, and central venous pressure in pure laparoscopic hepatectomy. Ann Surg. 2016;263:1159–63.CrossRefPubMed Kobayashi S, Honda G, Kurata M, et al. An experimental study on the relationship among airway pressure, pneumoperitoneum pressure, and central venous pressure in pure laparoscopic hepatectomy. Ann Surg. 2016;263:1159–63.CrossRefPubMed
10.
Zurück zum Zitat Shetty S, Sharma N, Ghosh K. Epidemiology of hepatocellular carcinoma (HCC) in hemophilia. Crit Rev Oncol Hematol. 2016;99:129–33.CrossRefPubMed Shetty S, Sharma N, Ghosh K. Epidemiology of hepatocellular carcinoma (HCC) in hemophilia. Crit Rev Oncol Hematol. 2016;99:129–33.CrossRefPubMed
11.
Zurück zum Zitat Shen SC, Harada A, Kurokawa T, et al. Partial hepatectomy for hepatocellular carcinoma in a patient with hemophilia: a case report. Hepatogastroenterology. 1994;41:283–6.PubMed Shen SC, Harada A, Kurokawa T, et al. Partial hepatectomy for hepatocellular carcinoma in a patient with hemophilia: a case report. Hepatogastroenterology. 1994;41:283–6.PubMed
12.
Zurück zum Zitat Narushima Y, Ishiyama S, Kawashima K, et al. Operated hepatocellular carcinoma in two HIV− and HCV-positive hemophilic patients. J Hepato-Bil Pancreat Surg. 2004;11:207–10. Narushima Y, Ishiyama S, Kawashima K, et al. Operated hepatocellular carcinoma in two HIV− and HCV-positive hemophilic patients. J Hepato-Bil Pancreat Surg. 2004;11:207–10.
13.
Zurück zum Zitat Jones AE, Roy A, Armstrong T, et al. Successful liver surgery in a haemophilia patient with high titre factor VIII inhibitor. Haemophilia. 2009;15:1332–3.CrossRefPubMed Jones AE, Roy A, Armstrong T, et al. Successful liver surgery in a haemophilia patient with high titre factor VIII inhibitor. Haemophilia. 2009;15:1332–3.CrossRefPubMed
14.
Zurück zum Zitat Hasegawa K, Takemura N, Yamashita T, et al. Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC guidelines). Hepatol Res. 2023;53:383–90.CrossRefPubMed Hasegawa K, Takemura N, Yamashita T, et al. Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC guidelines). Hepatol Res. 2023;53:383–90.CrossRefPubMed
15.
Zurück zum Zitat Ng KKC, Chok KSH, Chan ACY, et al. Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma. Br J Surg. 2017;104:1775–84.CrossRefPubMed Ng KKC, Chok KSH, Chan ACY, et al. Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma. Br J Surg. 2017;104:1775–84.CrossRefPubMed
16.
Zurück zum Zitat Takayama T, Hasegawa K, Izumi N, et al. Surgery versus radiofrequency ablation for small hepatocellular carcinoma: a randomized controlled trial (SURF trial). Liver Cancer. 2021;29:209–18. Takayama T, Hasegawa K, Izumi N, et al. Surgery versus radiofrequency ablation for small hepatocellular carcinoma: a randomized controlled trial (SURF trial). Liver Cancer. 2021;29:209–18.
17.
Zurück zum Zitat Goka R, Morimoto N, Miura K, et al. Successful treatment of hepatocellular carcinoma by laparoscopic radiofrequency ablation in a patient with hemophilia A. Clin J Gastroenterol. 2020;13:907–13.CrossRefPubMed Goka R, Morimoto N, Miura K, et al. Successful treatment of hepatocellular carcinoma by laparoscopic radiofrequency ablation in a patient with hemophilia A. Clin J Gastroenterol. 2020;13:907–13.CrossRefPubMed
18.
Zurück zum Zitat Yoshimoto-Haramura T, Hidaka M, Hasegawa K, et al. National survey of hepatobiliary and pancreatic surgery in hemophilia patients in Japan. J Hepato-Bil Pancreat Sci. 2022;29:385–93.CrossRef Yoshimoto-Haramura T, Hidaka M, Hasegawa K, et al. National survey of hepatobiliary and pancreatic surgery in hemophilia patients in Japan. J Hepato-Bil Pancreat Sci. 2022;29:385–93.CrossRef
19.
Zurück zum Zitat Matsuda T, Umeda Y, Yoshida K, et al. Laparoscopic Hepatectomy for the patient with hemophilia a with high titer factor VIII inhibitor. Acta Med Okayama. 2021;75:199–204.PubMed Matsuda T, Umeda Y, Yoshida K, et al. Laparoscopic Hepatectomy for the patient with hemophilia a with high titer factor VIII inhibitor. Acta Med Okayama. 2021;75:199–204.PubMed
20.
Zurück zum Zitat Yin Z, Fan X, Ye H, et al. Short- and long-term outcomes after laparoscopic and open hepatectomy for hepatocellular carcinoma: a global systematic review and meta-analysis. Ann Surg Oncol. 2013;20:1203–15.CrossRefPubMed Yin Z, Fan X, Ye H, et al. Short- and long-term outcomes after laparoscopic and open hepatectomy for hepatocellular carcinoma: a global systematic review and meta-analysis. Ann Surg Oncol. 2013;20:1203–15.CrossRefPubMed
21.
Zurück zum Zitat Takahara T, Wakabayashi G, Beppu T, et al. Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study. J Hepato-Bil Pancreat Sci. 2015;22:721–7.CrossRef Takahara T, Wakabayashi G, Beppu T, et al. Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study. J Hepato-Bil Pancreat Sci. 2015;22:721–7.CrossRef
22.
Zurück zum Zitat White GC 2nd, Rosendaal F, Aledort LM, et al. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 2001;85:560.CrossRefPubMed White GC 2nd, Rosendaal F, Aledort LM, et al. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 2001;85:560.CrossRefPubMed
23.
Zurück zum Zitat Takatsuki M, Natsuda K, Hidaka M, et al. The treatment choices and outcome of hepatocellular carcinoma in hemophilic patients with human immunodeficiency virus/hepatitis C virus (HIV/HCV) coinfection due to contaminated blood products in Japan. J Gastrointest Oncol. 2021;12:2952–9.CrossRefPubMedPubMedCentral Takatsuki M, Natsuda K, Hidaka M, et al. The treatment choices and outcome of hepatocellular carcinoma in hemophilic patients with human immunodeficiency virus/hepatitis C virus (HIV/HCV) coinfection due to contaminated blood products in Japan. J Gastrointest Oncol. 2021;12:2952–9.CrossRefPubMedPubMedCentral
Metadaten
Titel
Laparoscopic hepatectomy for hepatocellular carcinoma in patients with hemophilia A and B: a report of two cases
verfasst von
Mariko Tsukagoshi
Norifumi Harimoto
Kenichiro Araki
Norihiro Ishii
Kei Hagiwara
Kouki Hoshino
Kunio Yanagisawa
Yoshiyuki Ogawa
Hiroshi Handa
Ken Shirabe
Publikationsdatum
05.09.2023
Verlag
Springer Nature Singapore
Erschienen in
Clinical Journal of Gastroenterology / Ausgabe 6/2023
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-023-01854-2

Weitere Artikel der Ausgabe 6/2023

Clinical Journal of Gastroenterology 6/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.